Ranking Alexa Global: # 1,990,874
Server:Apache...
The main IP address: 134.0.20.66,Your server United Kingdom,Farnborough ISP:Wirehive Limited TLD:com CountryCode:GB
The description :astex – oncology and cns drug discovery & development discover astex our mission & values our leadership team harren jhoti david rees john lyons chris murray jeremy carmichael lee dawson tom h...
This report updates in 15-Jun-2018
Created Date: | 2002-08-20 |
Changed Date: | 2014-10-17 |
Expires Date: | 2021-08-20 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host astx.com. Currently, hosted in United Kingdom and its service provider is Wirehive Limited .
Latitude: | 51.294239044189 |
Longitude: | -0.7556499838829 |
Country: | United Kingdom (GB) |
City: | Farnborough |
Region: | England |
ISP: | Wirehive Limited |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
Transfer-Encoding: | chunked |
Set-Cookie: | PHPSESSID=78c59590d31ef8fdd0d9be254a870483; path=/ |
Expires: | Thu, 19 Nov 1981 08:52:00 GMT |
Server: | Apache |
Connection: | close |
Link: | |
X-UA-Compatible: | IE=edge,chrome=1 |
Pragma: | no-cache |
Cache-Control: | no-store, no-cache, must-revalidate, post-check=0, pre-check=0 |
Date: | Fri, 15 Jun 2018 15:29:02 GMT |
Content-Type: | text/html; charset=UTF-8 |
X-Pingback: | https://astx.com/xmlrpc.php |
soa: | ns33.domaincontrol.com. dns.jomax.net. 2017032400 28800 7200 604800 600 |
txt: | "v=spf1 include:_netblocks.mimecast.com ~all" "adobe-idp-site-verification=ebfac4c9-fdf3-4ec3-9fec-f91655f7a105" |
ns: | ns34.domaincontrol.com. ns33.domaincontrol.com. |
ipv4: | IP:134.0.20.66 ASN:56730 OWNER:WIREHIVE-AS, GB Country:GB |
mx: | MX preference = 10, mail exchanger = us-smtp-inbound-1.mimecast.com. MX preference = 10, mail exchanger = us-smtp-inbound-2.mimecast.com. |
astex – oncology and cns drug discovery & development discover astex our mission & values our leadership team harren jhoti david rees john lyons chris murray jeremy carmichael lee dawson tom heightman neil jones nicola wallis mohammad azab martin buckland harold n. keer nipun davar yong hao joseph iovino samuel jason charles lapree shinichi sato nancy worrell our history corporate social responsibility r&d clinical pipeline guadecitabine (sgi-110) dnmt inhibitor (treatment naïve aml) guadecitabine (sgi-110) dnmt inhibitor (relapsed/refractory aml) guadecitabine (sgi-110) dnmt inhibitor (relapsed/refractory mds or cmml) guadecitabine (sgi-110) dnmt inhibitor (solid tumors) astx029 extracellular signal-related protein kinases (erk 1/2) inhibitor (solid tumors) astx727 oral dnmt inhibitor (hematologic malignancies) astx660 dual iap antagonist (solid tumors & lymphomas) kisqali®(ribociclib) cdk4/6 inhibitor (oncology) azd3293 (lanabecestat) beta secretase (bace) inhibitor (alzheimer’s disease) azd5363 pkb/akt inhibitor (oncology) jnj42756493 (erdafitinib) fgfr inhibitor (oncology) multiple targets and therapeutic areas pyramid™ discovery platform oncology and cns discovery sustaining innovation partnering our people career opportunities media press releases press releases – archive conferences & meetings presentations & publications astex in the news contact search menu you are here: home world leading innovative drug discovery and development astex has built a rich product portfolio with multiple drugs in clinical development committed to the fight against cancer and cns disorders previous next 1 2 3 world leading innovative drug discovery and development astex has built a rich product portfolio with multiple drugs in clinical development committed to the fight against cancer and cns disorders previous next 1 2 3 learn more about the discovery and approval of kisqali ® robust portfolio of proprietary clinical stage oncology products and partnered products actively building an oncology and cns pipeline using a science-driven, open innovation approach we’re a member of the otsuka group of companies employment opportunities at our headquarters in uk and usa explore our scientific and clinical publications and presentations sustaining innovation innovative postdoctoral research fellowships learn more copyright © astex pharmaceuticals all rights reserved useful links home sitemap privacy policy terms of use legal member of the otsuka group scroll to top by continuing to use this website you will be agreeing to our terms & conditions , our privacy policy , and the use of cookies. continue
https://astx.com//#3
https://astx.com//#2
https://astx.com//#1
https://astx.com/our-people-and-culture/
https://astx.com///portfolio-item/nipun-davar/
https://astx.com///research-development/partnered-products-and-programs/kisqali-ribociclib-cdk46-inhibitor-oncology/
https://astx.com/research-development/partnered-products-and-programs/jnj42756493-erdafitinib-fgfr-inhibitor-oncology/
https://astx.com///portfolio-item/david-rees/
https://astx.com/research-development/sustaining-innovation/
https://astx.com///portfolio-item/mohammad-azab/
https://astx.com/research-development/pyramid-discovery-platform/
https://astx.com///portfolio-item/tom-heightman/
https://astx.com/research-development/clinical-pipeline/astx727-oral-dnmt-inhibitor-hematologic-malignancies/
https://astx.com/
https://astx.com///portfolio-item/nicola-wallis/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: ASTX.COM
Registrar URL: http://www.godaddy.com
Registrant Name:
Registrant Organization: SuperGen
Name Server: NS33.DOMAINCONTROL.COM
Name Server: NS34.DOMAINCONTROL.COM
DNSSEC: unsigned
For complete domain details go to:
http://who.godaddy.com/whoischeck.aspx?domain=ASTX.COM
The data contained in GoDaddy.com, LLC's WhoIs database,
while believed by the company to be reliable, is provided "as is"
with no guarantee or warranties regarding its accuracy. This
information is provided for the sole purpose of assisting you
in obtaining information about domain name registration records.
Any use of this data for any other purpose is expressly forbidden without the prior written
permission of GoDaddy.com, LLC. By submitting an inquiry,
you agree to these terms of usage and limitations of warranty. In particular,
you agree not to use this data to allow, enable, or otherwise make possible,
dissemination or collection of this data, in part or in its entirety, for any
purpose, such as the transmission of unsolicited advertising and
and solicitations of any kind, including spam. You further agree
not to use this data to enable high volume, automated or robotic electronic
processes designed to collect or compile this data for any purpose,
including mining this data for your own personal or commercial purposes.
Please note: the registrant of the domain name is specified
in the "registrant" section. In most cases, GoDaddy.com, LLC
is not the registrant of domain names listed in this database.
REGISTRAR GODADDY.COM, LLC
REFERRER http://www.godaddy.com
SERVERS
SERVER com.whois-servers.net
ARGS domain =astx.com
PORT 43
SERVER whois.godaddy.com
ARGS astx.com
PORT 43
TYPE domain
DOMAIN
NAME astx.com
NSERVER
NS33.DOMAINCONTROL.COM 216.69.185.17
NS34.DOMAINCONTROL.COM 208.109.255.17
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientRenewProhibited https://icann.org/epp#clientRenewProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
CHANGED 2014-10-17
CREATED 2002-08-20
EXPIRES 2021-08-20
OWNER
ADMIN
TECH
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .